slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 20,251-20,280
Pages 2,605
Rows per page 30
Component
20,251-20,280 of 78,129
06
Includes pro-forma data and forward-looking projections for 2022-2025.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 2 hits
38
Shows strong revenue growth (+73%) alongside stable adjusted EBITDA.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials2 hits
39
The slide uses stacked bar charts to illustrate the impact of acquisitions and future investments on financial performance.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials2 hits
41
Uses donut charts to show shifts in revenue composition.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials2 hits
48
Includes median lines for peer group; highlights Lanvin Group valuation at deal vs with bonus shares.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 2 hits
51
The slide uses a waterfall chart to decompose revenue growth into specific channels like retail, wholesale, e-commerce, and others.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 2 hits
52
Uses waterfall charts to decompose revenue growth drivers.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 2 hits
54
The slide uses horizontal bar charts to compare current revenue figures of specific business units against larger industry players.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 2 hits
11
The slide displays two dot plots with error bars representing median and 25th/75th percentiles for different dose cohorts over time.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test2 hits
21
The slide displays two dot plots with error bars representing median and 25th/75th percentiles.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 2 hits
22
The slide presents two dot plots with error bars representing median and 25th/75th percentiles for FXN concentration and change from baseline.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 2 hits
30
Data shows functional replacement of hFXN and normalization of gene expression.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 2 hits
31
Data presented as line charts with error bars, comparing KO: CTI-1601, KO: Vehicle, and Wild-type: Vehicle.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 2 hits
32
Data presented as line charts showing percent change over time (weeks 4 and 8) for Ejection Function and Fractional Shortening.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 2 hits
12
TTM = Trailing Twelve Months; ODR = Owner Direct Revenue (implied context).Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
19
The slide uses bar charts to show revenue growth for two distinct product segments.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & Approach2 hits
36
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps2 hits
37
The slide uses a split-chart layout to show financial trends and operational guidance side-by-side.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps2 hits
07
Includes specific commentary on North America and International revenue drivers, as well as operating income growth factors.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Loop · Logic Chain2 hits
08
Includes year-over-year comparisons for FY21 vs FY22.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Loop · Logic Chain2 hits
16
Lindsay Corporation | Results Presentation Deck | 17 slidesLindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · Action2 hits
08
The chart combines a bar chart for QoQ Deposit Beta and a line chart for interest rates/costs.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
10
The slide shows a downward trend in efficiency ratio (positive) and a fluctuating trend in equity/assets.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
11
The slide displays two line charts tracking financial performance over time.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
12
The slide highlights financial performance metrics for MainStreet Bancshares, Inc. with specific footnotes regarding non-GAAP measures and valuation divergence.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain2 hits
14
The slide highlights a 38% CAGR for DDA and notes that core deposits make up 71% of the total.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction2 hits
16
The CAGR is calculated for the period 2015-2021.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction2 hits
12
Includes definitions for abbreviations and source citations.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
18
Study uses male DIO-NASH mice with 30-week GAND feeding and 9-week treatment regimen.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
22
Includes a bar chart for NASH diagnosis and a funnel diagram for Obesity patient progression.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits